In addition, carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are typical tumour markers that can be used for the diagnosis of CRC and show abnormally high expression levels in CRC patients [29]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.